Holen Sie sich die Stockscreener-App
52.17
0.56%
0.29
Finanzdaten der Moonlake Immunotherapeutics-Aktie (MLTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
31.88%
19.82
|
15.03 | 12.98 | 13.19 | 12.93 |
| Operating Income/Loss |
31.88%
-19.82
|
-15.03 | -12.98 | -13.19 | -12.93 |
| Income/Loss From Continuing Operations Before Tax |
77.29%
-13.91
|
-7.8431 | -11.59 | -12.35 | -12.22 |
| Income Tax Expense/Benefit |
58.55%
0.0703
|
0.0443 | 0.0289 | 0.0101 | 0.011 |
| Income/Loss From Continuing Operations After Tax |
77.19%
-13.98
|
-7.8874 | -11.62 | -12.35 | -12.22 |
|
Net Income/Loss
|
77.19%
-13.98
|
-7.8874 | -11.62 | -12.35 | -12.22 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
32.97%
-0.3019
|
-0.4503 | -2.1933 | -2.2141 | -3.2141 |
| Basic Average Shares |
1,622%
62.64
|
3.6369 | 53.52 | 43.72 | 39.06 |
| Diluted Average Shares |
1,622%
62.64
|
3.6369 | 53.52 | 43.72 | 39.06 |
| Basic Earnings Per Share |
120.00%
-0.22
|
-0.10 | -0.18 | -0.23 | -0.23 |
| Diluted Earnings Per Share |
120.00%
-0.22
|
-0.10 | -0.18 | -0.23 | -0.23 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):